Related Experiment Video
Updated: Oct 10, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal urinary metabolites of polycyclic aromatic hydrocarbons and toddler cognition, language, and behavior
Erin R Wallace1, Yu Ni1, Christine T Loftus1
1Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA, USA.
Insights
Prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) showed some links to toddler neurodevelopmental issues in a U.S. study. Certain PAH metabolites were associated with neurodevelopmental delay and altered cognitive and language scores.
Area of Science:
- Environmental Health
- Neurodevelopmental Toxicology
- Epidemiology
Background:
- Animal and epidemiological studies suggest prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) may negatively impact toddler neurodevelopment.
- PAHs are environmental pollutants linked to various adverse health outcomes.
Purpose of the Study:
- To investigate the association between prenatal exposure to PAHs and neurodevelopmental outcomes in toddlers.
- To examine specific PAH metabolites and their impact on cognitive, language, and behavioral development.
Main Methods:
- Study included 835 mother-child pairs from a diverse pregnancy cohort in the U.S.
- PAH metabolite concentrations measured in maternal urine during mid-pregnancy.
- Neurodevelopmental outcomes assessed using Bayley Scales of Infant and Toddler Development (Bayley-3) and Brief Infant and Toddler Social Emotional Assessment (BITSEA).
- Multivariate regression and Weighted Quantile Sum Regression (WQS) used to analyze associations.
Main Results:
- 1-hydroxypyrene associated with increased risk of neurodevelopmental delay at age 2.
- 1-hydroxynaphthalene associated with lower risk of behavior problems at age 2.
- Combined 1- and 9-hydroxyphenanthrene associated with higher cognitive scores at age 3.
- PAH mixtures showed associations with both lower language and higher cognitive scores at different ages.
Conclusions:
- The study provides some support for adverse associations between prenatal PAH exposure and neurodevelopment in a southern U.S. population.
- Specific PAH metabolites may have differential effects on various aspects of neurodevelopment.
- Further research is needed to understand the complex mixture effects of PAHs on child development.
Background:
Animal and epidemiological studies suggest that prenatal exposure to polycyclic aromatic hydrocarbons (PAHs) may negatively impact toddler neurodevelopment.
Methods:
We investigated this association in 835 mother-child pairs from CANDLE, a diverse pregnancy cohort in the mid-South region of the U.S. PAH metabolite concentrations were measured in mid-pregnancy maternal urine. Cognitive and Language composite scores at ages 2 and 3 years were derived from the Bayley Scales of Infant and Toddler Development, 3rd edition (Bayley-3). Behavior Problem and Competence scores at age 2 were derived from the Brief Infant and Toddler Social Emotional Assessment (BITSEA). We used multivariate linear or Poisson regression to estimate associations with continuous scores and relative risks (RR) of neurodevelopment delay or behavior problems per 2-fold increase in PAH, adjusted for maternal health, nutrition, and socioeconomic status. Secondary analyses investigated associations with PAH mixture using Weighted Quantile Sum Regression (WQS) with a permutation test extension.
Results:
1- hydroxypyrene was associated with elevated relative risk for Neurodevelopmental Delay at age 2 (RR = 1.20, 95% CI: 1.03,1.39). Contrary to hypotheses, 1-hydroxynaphthalene was associated with lower risk for Behavior Problems at age 2 (RR = 0.90, 95% CI: 0.83,0.98), and combined 1- and 9-hydroxyphenanthrene was associated with 0.52-point higher (95% CI: 0.11,0.93) Cognitive score at age 3. For PAH mixtures, a quintile increase in hydroxy-PAH mixture was associated with lower Language score at age 2 (βwqs = -1.59; 95% CI: -2.84, -0.34; ppermutation = 0.07) and higher Cognitive score at age 3 (βwqs = 0.96; 95% CI: 0.11, 1.82; ppermutation = 0.05). All other estimates were consistent with null associations.
Conclusion:
In this large southern U.S. population we observed some support for adverse associations between PAHs and neurodevelopment.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Teratogenicity
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

